Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Kasuwancin Vertex Pharmaceuticals Incorporated

Rahoto kan sakamakon kudi na kamfanin Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals Incorporated shekara-shekara na samun kudin shiga ga shekara ta 2024. Yaushe Vertex Pharmaceuticals Incorporated buga rahotanni na kudi?
Ƙara zuwa widget din
Ƙara zuwa widget din

Vertex Pharmaceuticals Incorporated jimlar kudaden shiga, ribar shiga gida da kuma sauye-sauye na canje-canje a Yuro a yau

Vertex Pharmaceuticals Incorporated kudin shiga da kudin shiga na yanzu don sabon rahotonni. Canjin Vertex Pharmaceuticals Incorporated kudaden shiga da ya samu ta hanyar 69 065 000 € a tsawon bara. Kudin shiga yanar gizo Vertex Pharmaceuticals Incorporated - 66 924 000 €. Ana amfani da bayani game da kudin shiga na yanar gizo daga hanyoyin budewa. Vertex Pharmaceuticals Incorporated ginshiƙi akan rahoton hada-hadar kudi ta yanar gizo. Vertex Pharmaceuticals Incorporated rahoton rahoton kuɗi akan allon zane a ainihin lokacin yana nuna kuzarin, canji a cikin ƙayyadaddun kadarorin kamfanin. Darajar “kudin shiga” Vertex Pharmaceuticals Incorporated akan hoton aka nuna shi da shuɗi.

Rahoton Rahoton Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
kuma Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
kuma Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
30/06/2021 1 647 305 393.61 € +90.52 % ↑ 61 473 240.97 € -74.975 % ↓
31/03/2021 1 583 865 530.67 € +100.87 % ↑ 599 941 869.31 € +143.14 % ↑
31/12/2020 1 495 238 944.46 € +15.18 % ↑ 554 980 537.07 € +3.59 % ↑
30/09/2020 1 412 983 441.86 € +61.95 % ↑ 613 073 503 € +1 060.390 % ↑
31/12/2019 1 298 158 805.55 € - 535 731 340.40 € -
30/09/2019 872 467 358.88 € - 52 833 331.45 € -
30/06/2019 864 627 509.03 € - 245 645 873.13 € -
31/03/2019 788 518 044.56 € - 246 751 810.94 € -
Nuna:
To

Rahoton kudi Vertex Pharmaceuticals Incorporated, tsarawa

Zamanin sabbin bayanan kudi na Vertex Pharmaceuticals Incorporated: 31/03/2019, 31/03/2021, 30/06/2021. Kwanan bayanan bayanan kuɗi ana kiyaye su ta hanyar doka da kuma bayanan kuɗi. Rahoton sabon kudi na Vertex Pharmaceuticals Incorporated yana nan akan layi akan irin wannan ranar - 30/06/2021. Babban riba Vertex Pharmaceuticals Incorporated shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa. Babban riba Vertex Pharmaceuticals Incorporated ne 158 308 000 €

Dates na kudi rahotanni Vertex Pharmaceuticals Incorporated

Ribar kuɗi Vertex Pharmaceuticals Incorporated shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton. Ribar kuɗi Vertex Pharmaceuticals Incorporated ne 66 924 000 €

30/06/2021 31/03/2021 31/12/2020 30/09/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Babban riba
Babban riba shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa.
145 414 288.32 € 988 365 783.66 € 880 097 778.66 € 788 662 257.38 € 715 279 976.76 € 240 629 655.20 € 391 727 949.49 € 389 331 444.71 €
Farashin farashi
Kudin shi ne yawan kuɗin da aka samar da rarraba kayayyaki da ayyuka na kamfanin.
1 501 891 105.29 € 595 499 747.01 € 615 141 165.81 € 624 321 184.49 € 582 878 828.79 € 631 837 703.69 € 472 899 559.54 € 399 186 599.85 €
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
1 647 305 393.61 € 1 583 865 530.67 € 1 495 238 944.46 € 1 412 983 441.86 € 1 298 158 805.55 € 872 467 358.88 € 864 627 509.03 € 788 518 044.56 €
Hanyoyin shiga
Hanyoyin sarrafa kuɗi sun karu daga asusun kasuwancin kamfanin. Alal misali, mai sayar da kaya yana haifar da samun kudin shiga ta hanyar sayar da kayayyaki, kuma likita ya karbi kuɗi daga sabis na kiwon lafiya wanda ya bayar.
- - - - - - - -
Haɗin aiki
Sakamakon aiki yana da ma'auni na lissafin kudi wanda ke daidaita yawan ribar da aka samu daga ayyukan kasuwanci, bayan da ya rage kudaden aiki, kamar albashi, haɓakawa da kuma kaya na kaya da aka sayar.
-33 399 505.63 € 811 932 879.08 € 685 508 755.48 € 619 142 382.67 € 538 406 166.74 € 93 960 623.48 € 247 972 567.88 € 254 262 818.82 €
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
61 473 240.97 € 599 941 869.31 € 554 980 537.07 € 613 073 503 € 535 731 340.40 € 52 833 331.45 € 245 645 873.13 € 246 751 810.94 €
R & D kudi
Binciken bincike da ci gaba - kudaden bincike don inganta samfurori da hanyoyin da ake samuwa ko kuma samar da sababbin samfurori da hanyoyin.
- - - - - - - -
Ayyukan sarrafawa
Kayan aiki shine kudaden da kasuwancin ke haifarwa saboda sakamakon ayyukan kasuwanci na yau da kullum.
1 680 704 899.24 € 771 932 651.59 € 809 730 188.98 € 793 841 059.19 € 759 752 638.81 € 778 506 735.41 € 616 654 941.15 € 534 255 225.73 €
Abubuwan da ke yanzu
Abubuwan da ake amfani da su a yanzu shine takarda na ma'auni wanda ya wakilta dukiyar dukiyar da za'a iya juyo cikin kuɗi a cikin shekara guda.
7 768 674 857.24 € 7 843 806 062.77 € 7 470 939 680.59 € 6 850 987 134.17 € 4 233 899 202.64 € 4 388 014 024.98 € 4 327 273 789.30 € 3 842 343 022.57 €
Total dukiya
Jimlar dukiyar kuɗi ce ta kuɗin kuɗin kuɗin kuɗin kuɗin kungiyar, bashin bashi, da dukiya na kayan aiki.
11 226 266 340.36 € 11 128 323 789.63 € 10 794 658 493.82 € 10 381 148 897.05 € 7 640 950 981.15 € 6 902 515 201.81 € 6 460 615 887.46 € 6 010 196 994.04 €
Kudi na yanzu
Kasuwanci na yanzu shine kudaden kuɗin da kamfanin ya gudanar a ranar rahoton.
5 569 809 617.93 € 5 790 861 234.49 € 5 500 467 133.41 € 4 921 686 888.11 € 3 498 119 878.58 € 3 121 188 899.37 € 3 026 341 872.25 € 2 658 186 748.41 €
Yanzu bashi
Dalili na yanzu shine ɓangare na bashin da za a biya a wannan shekara (watannin 12) kuma an nuna shi a matsayin wani alhaki na yanzu da kuma ɓangare na babban kamfanonin aiki.
- - - - 1 106 417 296.67 € 1 275 772 750.38 € 1 156 660 308.66 € 1 016 349 500.80 €
Jimlar kuɗi
Jimlar kuɗin kuɗi ne adadin duk kuɗin da kamfanin yake da shi a cikin asusunsa, ciki har da ƙananan kuɗi da kudade da aka gudanar a banki.
- - - - - - - -
Jimlar bashi
Jimlar bashi shine haɗuwa da gajeren lokaci da dogon lokaci. Lokaci bashi ne waɗanda dole ne a biya a cikin shekara guda. Lokaci na dogon lokaci ya hada da dukan wajibai waɗanda dole ne a biya su bayan shekara guda.
- - - - 2 051 331 849.21 € 2 076 994 382.93 € 1 803 584 326.82 € 1 671 583 667.95 €
Yanayin bashi
Jimlar bashi ga duk dukiya shi ne haɗin kudi wanda ya nuna yawan yawan dukiyar da kamfanin ke wakilta a matsayin bashi.
- - - - 26.85 % 30.09 % 27.92 % 27.81 %
Hakki
Adalci shine adadin dukan dukiya na mai shi bayan da ya cire duk wata albashi daga dukiyar kuɗi.
8 447 377 134.99 € 8 248 839 252.46 € 7 979 299 978.70 € 7 471 026 024.57 € 5 589 619 131.93 € 4 825 520 818.88 € 4 657 031 560.65 € 4 338 613 326.09 €
Cash flow
Cash flow is bashin tsabar kuɗi da tsabar kuɗin da ake ciki a cikin kungiyar.
- - - - 409 681 986.42 € 307 521 440.32 € 425 978 035.20 € 298 331 317.55 €

Rahoton kudi na baya-bayan nan game da kudin shiga na Vertex Pharmaceuticals Incorporated shine ranar 30/06/2021. A cewar sabon rahoto game da sakamakon kudi na Vertex Pharmaceuticals Incorporated, yawan kudaden da Vertex Pharmaceuticals Incorporated ya samu ya kai 1 647 305 393.61 Yuro kuma ya canza zuwa +90.52% idan aka kwatanta da shekara ta gaba. Sakamakon riba na Vertex Pharmaceuticals Incorporated a cikin kwata na karshe shine 61 473 240.97 €, karuwar riba ta karu da -74.975% idan aka kwatanta da bara.

Kudin hannun jari Vertex Pharmaceuticals Incorporated

Finance Vertex Pharmaceuticals Incorporated